Trametinib Treatment for Complicated Vascular Anomalies
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
Complicated vascular anomalies have diverse etiologies and variable clinical manifestations, and no standardized treatment protocol has been established. Since most patients present with diffuse lesions that are difficult to resect surgically, identifying effective therapeutic strategies is of critical importance. This study aims to evaluate the safety and efficacy of systemic trametinib therapy in patients with complicated vascular anomalies.